Timpani Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Timpani Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-55,582	Closed	-$2.2M	–	95
2015 Q3	$2.2M	Sell	55,582 -90,236	-62%	-$5.13M	0.89%	53
2015 Q2	$9.05M	Buy	145,818 +12,392	+9%	+$737K	2.62%	3
2015 Q1	$8.35M	Buy	133,426 +25,641	+24%	+$1.56M	2.49%	4
2014 Q4	$6.08M	Buy	107,785 +42,039	+64%	+$1.85M	2.39%	4
2014 Q3	$1.86M	Buy	65,746 +20,881	+47%	+$626K	0.85%	50
2014 Q2	$1.54M	Sell	44,865 -29,953	-40%	-$939K	0.69%	57
2014 Q1	$2.35M	Buy	+74,818	New	+$1.99M	1.24%	32

Other funds holding ANIP

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Timpani Capital Management's ANIP Position: Q4 2015 in Review

Timpani Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2015, closing a stake of 55,582 shares — an estimated $2.2M sold.

Timpani Capital Management first reported a position in ANIP in Q1 2014 and held it in 7 quarters. The position peaked at $9.05M in Q2 2015. 123 funds tracked by Wall St. Rank hold ANIP as of Q4 2015.

Timpani Capital Management reported no remaining ANI Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Timpani Capital Management sold 55,582 ANI Pharmaceuticals shares in Q4 2015, an estimated $2.2M.
Timpani Capital Management first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 7 quarters.
Timpani Capital Management's ANI Pharmaceuticals position peaked at $9.05M in Q2 2015.
123 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2015.

Based on Timpani Capital Management's 13F filing for Q4 2015, filed 4 Feb 2016.